Advertisement

Index by author

May 01, 1987; Volume 241,Issue 2

A

  1. Ageel, A M

    1. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
      M Tariq, N S Parmar and A M Ageel
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 602-607;

  2. Ahlijanian, M K

    1. Antagonism of calmodulin-stimulated adenylate cyclase by trifluoperazine, calmidazolium and W-7 in rat cerebellar membranes.
      M K Ahlijanian and D M Cooper
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 407-414;

  3. Alvares, A P

    1. Regulation of heme metabolism and monooxygeneses in liver and kidney: influence of therapeutically used gold compounds.
      J A Gondal, J L Eiseman and A P Alvares
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 540-546;

  4. Ambrosio, G

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  5. Apelgren, L D

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
      M E Spearman, R M Goodwin, L D Apelgren and T F Bumol
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 695-703;

  6. Arora, P K

    1. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
      S I Harik, J W Schmidley, L A Iacofano, P Blue, P K Arora and L M Sayre
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 669-676;

B

  1. Baik, Y H

    1. A possible role for the endothelium in porcine coronary smooth muscle responses to dihydropyridine calcium channel modulators.
      J S Williams, Y H Baik, W J Koch and A Schwartz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 379-386;

  2. Balduini, W

    1. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
      W Balduini, S D Murphy and L G Costa
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 421-427;

  3. Balster, R L

    1. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice.
      D C Rees, J S Knisely, R L Balster, S Jordan and T J Breen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 507-515;

  4. Barth, T

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

  5. Beardsley, P M

    1. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
      P M Beardsley, J A Scimeca and B R Martin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 521-526;

  6. Belknap, J K

    1. Selective breeding for levorphanol-induced antinociception on the hot-plate assay: commonalities in mechanism of action with morphine, pentazocine, ethylketocyclazocine, U-50488H and clonidine in mice.
      J K Belknap, P W Danielson, S E Laursen and B Noordewier
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 477-481;

  7. Benson, R W

    1. A sensitive immunochemical assay for acetaminophen-protein adducts.
      D W Roberts, N R Pumford, D W Potter, R W Benson and J A Hinson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 527-533;

  8. Berkowitz, B A

    1. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
      E H Ohlstein, L I Kruse, M Ezekiel, S S Sherman, R Erickson, W E DeWolf and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 554-559;

  9. Bertko, R

    1. Pharmacokinetics and antisecretory activity of trimoprostil in Heidenhain-pouch dogs.
      R J Wills, H E Gallo-Torres, R Bertko and B H Min
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 433-437;

  10. Beyer, H S

    1. Attenuation of the plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats.
      B M Sharp, H S Beyer, A S Levine, J E Morley and K M McAllen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 438-442;

  11. Blue, P

    1. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
      S I Harik, J W Schmidley, L A Iacofano, P Blue, P K Arora and L M Sayre
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 669-676;

  12. Bondy, S C

    1. Modulation of levels of free calcium within synaptosomes by organochlorine insecticides.
      H Komulainen and S C Bondy
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 575-581;

  13. Bowler, J J

    1. Alpha-1 adrenergic coupling events induced by full and partial agonists in rabbit aorta.
      P F Wick, A C Keung, J J Bowler and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 458-464;

  14. Brandon, D D

    1. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.
      S Kawai, L K Nieman, D D Brandon, R Udelsman, D L Loriaux and G P Chrousos
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 401-406;

  15. Braunwalder, A

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  16. Breen, T J

    1. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice.
      D C Rees, J S Knisely, R L Balster, S Jordan and T J Breen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 507-515;

  17. Brookins, J

    1. Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia.
      R J McGonigle, J Brookins, B L Pegram and J W Fisher
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 428-432;

  18. Brtnik, F

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

  19. Bumol, T F

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
      M E Spearman, R M Goodwin, L D Apelgren and T F Bumol
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 695-703;

  20. Burnstock, G

    1. Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels.
      D A Houston, G Burnstock and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 501-506;

C

  1. Cappelli-Bigazzi, M

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  2. Carter, C

    1. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
      T Dennis, R L'Heureux, C Carter and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 642-649;

  3. Cash, W D

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  4. Cerletti, C

    1. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
      M Hatmi, A del Maschio, J Lefort, G de gaetano, B B Vargaftig and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 623-627;

  5. Cherry, P D

    1. Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung.
      P D Cherry and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 516-520;

  6. Chiariello, M

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  7. Chrousos, G P

    1. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.
      S Kawai, L K Nieman, D D Brandon, R Udelsman, D L Loriaux and G P Chrousos
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 401-406;

  8. Cohen, M L

    1. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
      D W Pomfret, K W Schenck, P Fludzinski and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 465-471;

  9. Condorelli, M

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  10. Cooke, J P

    1. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs.
      N A Flavahan, J P Cooke, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 361-365;

  11. Cooper, D M

    1. Antagonism of calmodulin-stimulated adenylate cyclase by trifluoperazine, calmidazolium and W-7 in rat cerebellar membranes.
      M K Ahlijanian and D M Cooper
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 407-414;

  12. Costa, L G

    1. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
      W Balduini, S D Murphy and L G Costa
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 421-427;

  13. Cusack, B J

    1. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men.
      R E Vestal, B J Cusack, G D Mercer, G W Dawson and B K Park
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 488-500;

D

  1. Danielson, P W

    1. Selective breeding for levorphanol-induced antinociception on the hot-plate assay: commonalities in mechanism of action with morphine, pentazocine, ethylketocyclazocine, U-50488H and clonidine in mice.
      J K Belknap, P W Danielson, S E Laursen and B Noordewier
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 477-481;

  2. Dawson, G W

    1. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men.
      R E Vestal, B J Cusack, G D Mercer, G W Dawson and B K Park
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 488-500;

  3. de gaetano, G

    1. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
      M Hatmi, A del Maschio, J Lefort, G de gaetano, B B Vargaftig and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 623-627;

  4. del Maschio, A

    1. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
      M Hatmi, A del Maschio, J Lefort, G de gaetano, B B Vargaftig and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 623-627;

  5. Dennis, T

    1. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
      T Dennis, R L'Heureux, C Carter and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 642-649;

  6. Deth, R C

    1. Alpha-1 adrenergic coupling events induced by full and partial agonists in rabbit aorta.
      P F Wick, A C Keung, J J Bowler and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 458-464;

  7. DeWolf, W E

    1. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
      E H Ohlstein, L I Kruse, M Ezekiel, S S Sherman, R Erickson, W E DeWolf and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 554-559;

  8. Driscoll, E M

    1. Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.
      J J Lynch, S D Nelson, S A MacEwen, E M Driscoll and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 741-749;

  9. Duckles, S P

    1. Effect of increasing age on the endothelium-mediated relaxation of rat blood vessels in vitro.
      M R Hynes and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 387-392;

E

  1. Eiseman, J L

    1. Regulation of heme metabolism and monooxygeneses in liver and kidney: influence of therapeutically used gold compounds.
      J A Gondal, J L Eiseman and A P Alvares
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 540-546;

  2. Eisenhofer, G

    1. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, R W Stull, D S Goldstein, H R Keiser and I J Kopin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 547-553;

  3. el-Fakahany, E E

    1. Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells.
      W S Lai and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 366-373;

  4. Erickson, R

    1. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
      E H Ohlstein, L I Kruse, M Ezekiel, S S Sherman, R Erickson, W E DeWolf and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 554-559;

  5. Ezekiel, M

    1. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
      E H Ohlstein, L I Kruse, M Ezekiel, S S Sherman, R Erickson, W E DeWolf and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 554-559;

F

  1. Fabisiak, J P

    1. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. I. Analysis, characterization and regulation of specific beta adrenergic receptors.
      J P Fabisiak, E S Vesell and D E Rannels
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 722-727;
    2. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. II. Receptor-independent accumulation of beta adrenergic antagonists and other cationic amphiphilic drugs in lamellar bodies.
      J P Fabisiak, E S Vesell and D E Rannels
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 728-735;

  2. Fisher, J W

    1. Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia.
      R J McGonigle, J Brookins, B L Pegram and J W Fisher
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 428-432;

  3. Flavahan, N A

    1. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs.
      N A Flavahan, J P Cooke, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 361-365;

  4. Fleming, W W

    1. Characteristics of adaptive supersensitivity in the left atrium of the guinea pig.
      M H Hawthorn, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 453-457;

  5. Fludzinski, P

    1. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
      D W Pomfret, K W Schenck, P Fludzinski and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 465-471;

  6. Francis, J

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  7. Frey, B M

    1. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
      S Fritz, W Lindner, I Roots, B M Frey and A Küpfer
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 615-622;

  8. Fritz, S

    1. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
      S Fritz, W Lindner, I Roots, B M Frey and A Küpfer
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 615-622;

  9. Fujiwara, M

    1. Gastric excitation by stimulation of the vagal trunk after chronic supranodose vagotomy in cats.
      T Tsubomura, T Okamoto, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 650-654;

G

  1. Gallo-Torres, H E

    1. Pharmacokinetics and antisecretory activity of trimoprostil in Heidenhain-pouch dogs.
      R J Wills, H E Gallo-Torres, R Bertko and B H Min
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 433-437;

  2. Gardner, E L

    1. Modulation of rat brain opioid receptors by cannabinoids.
      P J Vaysse, E L Gardner and R S Zukin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 534-539;

  3. Geary, W A

    1. In vitro and in vivo distribution and binding of phenytoin to rat brain.
      W A Geary, G F Wooten, J B Perlin and E W Lothman
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 704-713;

  4. Gerhardt, G A

    1. In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus.
      G A Gerhardt, K Pang and G M Rose
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 714-721;

  5. Gesek, F A

    1. In vivo assessment of rat renal alpha adrenoceptors.
      D W Wolff, F A Gesek and J W Strandhoy
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 472-476;

  6. Ghai, G

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  7. Giachetti, A

    1. AF-DX 116, a cardioselective muscarinic antagonist.
      R Micheletti, E Montagna and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 628-634;

  8. Gibb, J W

    1. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
      A A Letter, K Merchant, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 443-447;

  9. Gillis, C N

    1. Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung.
      P D Cherry and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 516-520;

  10. Goldstein, D S

    1. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, R W Stull, D S Goldstein, H R Keiser and I J Kopin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 547-553;

  11. Gondal, J A

    1. Regulation of heme metabolism and monooxygeneses in liver and kidney: influence of therapeutically used gold compounds.
      J A Gondal, J L Eiseman and A P Alvares
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 540-546;

  12. Goodwin, R M

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
      M E Spearman, R M Goodwin, L D Apelgren and T F Bumol
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 695-703;

  13. Goto, K

    1. Inhibitory effect of calcitonin gene-related peptide on excitation and contraction of smooth muscles of the rat vas deferens.
      K Goto, S Kimura and A Saito
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 635-641;

H

  1. Hall, J

    1. Skin absorption and cutaneous first pass metabolism of topical steroids: in vitro studies with mouse skin in organ culture.
      J Kao and J Hall
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 482-487;

  2. Hanson, G R

    1. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
      A A Letter, K Merchant, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 443-447;

  3. Harik, S I

    1. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
      S I Harik, J W Schmidley, L A Iacofano, P Blue, P K Arora and L M Sayre
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 669-676;

  4. Harris, L T

    1. Characterization of the central sympathoinhibitory action of ketanserin.
      R B McCall and L T Harris
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 736-740;

  5. Hatmi, M

    1. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
      M Hatmi, A del Maschio, J Lefort, G de gaetano, B B Vargaftig and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 623-627;

  6. Hawthorn, M H

    1. Characteristics of adaptive supersensitivity in the left atrium of the guinea pig.
      M H Hawthorn, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 453-457;

  7. Heyman, J S

    1. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
      F Porreca, J S Heyman, H I Mosberg, J R Omnaas and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 393-400;

  8. Hinson, J A

    1. A sensitive immunochemical assay for acetaminophen-protein adducts.
      D W Roberts, N R Pumford, D W Potter, R W Benson and J A Hinson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 527-533;

  9. Hirooka, H

    1. H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine.
      A Tsuji, T Terasaki, I Tamai and H Hirooka
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 594-601;

  10. Houston, D A

    1. Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels.
      D A Houston, G Burnstock and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 501-506;

  11. Huidobro-Toro, J P

    1. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: evidence for different structural prerequisites.
      I Llona, R Vavrek, J Stewart and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 608-614;

  12. Hynes, M D

    1. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
      D M Zimmerman, J D Leander, J K Reel and M D Hynes
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 374-378;

  13. Hynes, M R

    1. Effect of increasing age on the endothelium-mediated relaxation of rat blood vessels in vitro.
      M R Hynes and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 387-392;

I

  1. Iacofano, L A

    1. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
      S I Harik, J W Schmidley, L A Iacofano, P Blue, P K Arora and L M Sayre
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 669-676;

  2. Ishii, K

    1. Suppression by muscarinic M2 stimulation of the contractile mechanism via histamine H1 receptors in the longitudinal muscle of guinea pig ileum.
      K Ishii and R Kato
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 587-593;

  3. Itoh, Y

    1. Mechanism of the central hyperglycemic action of histamine in mice.
      M Nishibori, Y Itoh, R Oishi and K Saeki
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 582-586;

  4. Izbéki, F

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

J

  1. Jordan, S

    1. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice.
      D C Rees, J S Knisely, R L Balster, S Jordan and T J Breen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 507-515;

  2. Jost, K

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

K

  1. Kao, J

    1. Skin absorption and cutaneous first pass metabolism of topical steroids: in vitro studies with mouse skin in organ culture.
      J Kao and J Hall
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 482-487;

  2. Kato, R

    1. Suppression by muscarinic M2 stimulation of the contractile mechanism via histamine H1 receptors in the longitudinal muscle of guinea pig ileum.
      K Ishii and R Kato
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 587-593;

  3. Kawai, S

    1. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.
      S Kawai, L K Nieman, D D Brandon, R Udelsman, D L Loriaux and G P Chrousos
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 401-406;

  4. Keiser, H R

    1. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, R W Stull, D S Goldstein, H R Keiser and I J Kopin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 547-553;

  5. Keung, A C

    1. Alpha-1 adrenergic coupling events induced by full and partial agonists in rabbit aorta.
      P F Wick, A C Keung, J J Bowler and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 458-464;

  6. Kimura, S

    1. Inhibitory effect of calcitonin gene-related peptide on excitation and contraction of smooth muscles of the rat vas deferens.
      K Goto, S Kimura and A Saito
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 635-641;

  7. Knisely, J S

    1. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice.
      D C Rees, J S Knisely, R L Balster, S Jordan and T J Breen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 507-515;

  8. Koch, W J

    1. A possible role for the endothelium in porcine coronary smooth muscle responses to dihydropyridine calcium channel modulators.
      J S Williams, Y H Baik, W J Koch and A Schwartz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 379-386;

  9. Komulainen, H

    1. Modulation of levels of free calcium within synaptosomes by organochlorine insecticides.
      H Komulainen and S C Bondy
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 575-581;

  10. Kopin, I J

    1. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, R W Stull, D S Goldstein, H R Keiser and I J Kopin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 547-553;

  11. Kovács, G L

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

  12. Kruse, L I

    1. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
      E H Ohlstein, L I Kruse, M Ezekiel, S S Sherman, R Erickson, W E DeWolf and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 554-559;

  13. Küpfer, A

    1. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
      S Fritz, W Lindner, I Roots, B M Frey and A Küpfer
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 615-622;

  14. Kurahashi, K

    1. Gastric excitation by stimulation of the vagal trunk after chronic supranodose vagotomy in cats.
      T Tsubomura, T Okamoto, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 650-654;

  15. Kurtzman, N A

    1. Effect of parathyroid hormone fragments on calcium transport in toad bladder.
      S Sabatini, W C Yang and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 448-452;

L

  1. L'Heureux, R

    1. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
      T Dennis, R L'Heureux, C Carter and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 642-649;

  2. Lai, W S

    1. Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells.
      W S Lai and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 366-373;

  3. Laursen, S E

    1. Selective breeding for levorphanol-induced antinociception on the hot-plate assay: commonalities in mechanism of action with morphine, pentazocine, ethylketocyclazocine, U-50488H and clonidine in mice.
      J K Belknap, P W Danielson, S E Laursen and B Noordewier
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 477-481;

  4. Leander, J D

    1. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
      D M Zimmerman, J D Leander, J K Reel and M D Hynes
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 374-378;

  5. Lefort, J

    1. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
      M Hatmi, A del Maschio, J Lefort, G de gaetano, B B Vargaftig and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 623-627;

  6. Letter, A A

    1. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
      A A Letter, K Merchant, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 443-447;

  7. Levine, A S

    1. Attenuation of the plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats.
      B M Sharp, H S Beyer, A S Levine, J E Morley and K M McAllen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 438-442;

  8. Lindner, W

    1. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
      S Fritz, W Lindner, I Roots, B M Frey and A Küpfer
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 615-622;

  9. Llona, I

    1. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: evidence for different structural prerequisites.
      I Llona, R Vavrek, J Stewart and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 608-614;

  10. Loriaux, D L

    1. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.
      S Kawai, L K Nieman, D D Brandon, R Udelsman, D L Loriaux and G P Chrousos
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 401-406;

  11. Lothman, E W

    1. In vitro and in vivo distribution and binding of phenytoin to rat brain.
      W A Geary, G F Wooten, J B Perlin and E W Lothman
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 704-713;

  12. Lucchesi, B R

    1. Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.
      J J Lynch, S D Nelson, S A MacEwen, E M Driscoll and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 741-749;

  13. Lynch, J J

    1. Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.
      J J Lynch, S D Nelson, S A MacEwen, E M Driscoll and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 741-749;

M

  1. MacEwen, S A

    1. Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.
      J J Lynch, S D Nelson, S A MacEwen, E M Driscoll and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 741-749;

  2. Mark, M R

    1. Amino acid uptake in denervated rat parotid gland: I. Preparation and evaluation of a lobule system for in vitro studies.
      M R Mark
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 655-662;
    2. Amino acid uptake in the rat parotid gland: II. Effects of surgical sympathectomy and parasympathectomy.
      M R Mark
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 663-668;

  3. Marone, G

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  4. Martin, B R

    1. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
      P M Beardsley, J A Scimeca and B R Martin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 521-526;

  5. McAllen, K M

    1. Attenuation of the plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats.
      B M Sharp, H S Beyer, A S Levine, J E Morley and K M McAllen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 438-442;

  6. McCall, R B

    1. Characterization of the central sympathoinhibitory action of ketanserin.
      R B McCall and L T Harris
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 736-740;

  7. McGonigle, R J

    1. Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia.
      R J McGonigle, J Brookins, B L Pegram and J W Fisher
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 428-432;

  8. Mercer, G D

    1. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men.
      R E Vestal, B J Cusack, G D Mercer, G W Dawson and B K Park
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 488-500;

  9. Merchant, K

    1. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
      A A Letter, K Merchant, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 443-447;

  10. Micheletti, R

    1. AF-DX 116, a cardioselective muscarinic antagonist.
      R Micheletti, E Montagna and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 628-634;

  11. Min, B H

    1. Pharmacokinetics and antisecretory activity of trimoprostil in Heidenhain-pouch dogs.
      R J Wills, H E Gallo-Torres, R Bertko and B H Min
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 433-437;

  12. Montagna, E

    1. AF-DX 116, a cardioselective muscarinic antagonist.
      R Micheletti, E Montagna and A Giachetti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 628-634;

  13. Morley, J E

    1. Attenuation of the plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats.
      B M Sharp, H S Beyer, A S Levine, J E Morley and K M McAllen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 438-442;

  14. Mosberg, H I

    1. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
      F Porreca, J S Heyman, H I Mosberg, J R Omnaas and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 393-400;

  15. Murphy, S D

    1. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
      W Balduini, S D Murphy and L G Costa
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 421-427;

N

  1. Nelson, S D

    1. Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.
      J J Lynch, S D Nelson, S A MacEwen, E M Driscoll and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 741-749;

  2. Nevola, E

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  3. Nieman, L K

    1. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.
      S Kawai, L K Nieman, D D Brandon, R Udelsman, D L Loriaux and G P Chrousos
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 401-406;

  4. Nishibori, M

    1. Mechanism of the central hyperglycemic action of histamine in mice.
      M Nishibori, Y Itoh, R Oishi and K Saeki
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 582-586;

  5. Noordewier, B

    1. Selective breeding for levorphanol-induced antinociception on the hot-plate assay: commonalities in mechanism of action with morphine, pentazocine, ethylketocyclazocine, U-50488H and clonidine in mice.
      J K Belknap, P W Danielson, S E Laursen and B Noordewier
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 477-481;

O

  1. Ohlstein, E H

    1. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
      E H Ohlstein, L I Kruse, M Ezekiel, S S Sherman, R Erickson, W E DeWolf and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 554-559;

  2. Oishi, R

    1. Mechanism of the central hyperglycemic action of histamine in mice.
      M Nishibori, Y Itoh, R Oishi and K Saeki
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 582-586;

  3. Okamoto, T

    1. Gastric excitation by stimulation of the vagal trunk after chronic supranodose vagotomy in cats.
      T Tsubomura, T Okamoto, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 650-654;

  4. Olsen, R W

    1. gamma-Aminobutyric acid receptor-regulated 36Cl- flux in mouse cortical slices.
      J S Yang and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 677-685;

  5. Omnaas, J R

    1. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
      F Porreca, J S Heyman, H I Mosberg, J R Omnaas and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 393-400;

P

  1. Pang, K

    1. In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus.
      G A Gerhardt, K Pang and G M Rose
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 714-721;

  2. Park, B K

    1. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men.
      R E Vestal, B J Cusack, G D Mercer, G W Dawson and B K Park
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 488-500;

  3. Parmar, N S

    1. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
      M Tariq, N S Parmar and A M Ageel
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 602-607;

  4. Pegram, B L

    1. Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia.
      R J McGonigle, J Brookins, B L Pegram and J W Fisher
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 428-432;

  5. Perlin, J B

    1. In vitro and in vivo distribution and binding of phenytoin to rat brain.
      W A Geary, G F Wooten, J B Perlin and E W Lothman
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 704-713;

  6. Perrone-Filardi, P

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  7. Pomfret, D W

    1. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
      D W Pomfret, K W Schenck, P Fludzinski and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 465-471;

  8. Porreca, F

    1. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
      F Porreca, J S Heyman, H I Mosberg, J R Omnaas and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 393-400;

  9. Potter, D W

    1. A sensitive immunochemical assay for acetaminophen-protein adducts.
      D W Roberts, N R Pumford, D W Potter, R W Benson and J A Hinson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 527-533;

  10. Psychoyos, S

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  11. Pumford, N R

    1. A sensitive immunochemical assay for acetaminophen-protein adducts.
      D W Roberts, N R Pumford, D W Potter, R W Benson and J A Hinson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 527-533;

R

  1. Rannels, D E

    1. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. I. Analysis, characterization and regulation of specific beta adrenergic receptors.
      J P Fabisiak, E S Vesell and D E Rannels
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 722-727;
    2. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. II. Receptor-independent accumulation of beta adrenergic antagonists and other cationic amphiphilic drugs in lamellar bodies.
      J P Fabisiak, E S Vesell and D E Rannels
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 728-735;

  2. Reel, J K

    1. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
      D M Zimmerman, J D Leander, J K Reel and M D Hynes
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 374-378;

  3. Rees, D C

    1. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice.
      D C Rees, J S Knisely, R L Balster, S Jordan and T J Breen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 507-515;

  4. Roberts, D W

    1. A sensitive immunochemical assay for acetaminophen-protein adducts.
      D W Roberts, N R Pumford, D W Potter, R W Benson and J A Hinson
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 527-533;

  5. Roots, I

    1. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
      S Fritz, W Lindner, I Roots, B M Frey and A Küpfer
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 615-622;

  6. Ropchak, T G

    1. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, R W Stull, D S Goldstein, H R Keiser and I J Kopin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 547-553;

  7. Rose, G M

    1. In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus.
      G A Gerhardt, K Pang and G M Rose
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 714-721;

S

  1. Sabatini, S

    1. Effect of parathyroid hormone fragments on calcium transport in toad bladder.
      S Sabatini, W C Yang and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 448-452;

  2. Saeki, K

    1. Mechanism of the central hyperglycemic action of histamine in mice.
      M Nishibori, Y Itoh, R Oishi and K Saeki
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 582-586;

  3. Saito, A

    1. Inhibitory effect of calcitonin gene-related peptide on excitation and contraction of smooth muscles of the rat vas deferens.
      K Goto, S Kimura and A Saito
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 635-641;

  4. Sarnyai, Z

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

  5. Sayre, L M

    1. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
      S I Harik, J W Schmidley, L A Iacofano, P Blue, P K Arora and L M Sayre
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 669-676;

  6. Scatton, B

    1. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
      T Dennis, R L'Heureux, C Carter and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 642-649;

  7. Schenck, K W

    1. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
      D W Pomfret, K W Schenck, P Fludzinski and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 465-471;

  8. Schmidley, J W

    1. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
      S I Harik, J W Schmidley, L A Iacofano, P Blue, P K Arora and L M Sayre
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 669-676;

  9. Schwartz, A

    1. A possible role for the endothelium in porcine coronary smooth muscle responses to dihydropyridine calcium channel modulators.
      J S Williams, Y H Baik, W J Koch and A Schwartz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 379-386;

  10. Scimeca, J A

    1. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
      P M Beardsley, J A Scimeca and B R Martin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 521-526;

  11. Sharp, B M

    1. Attenuation of the plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats.
      B M Sharp, H S Beyer, A S Levine, J E Morley and K M McAllen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 438-442;

  12. Shepherd, J T

    1. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs.
      N A Flavahan, J P Cooke, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 361-365;

  13. Sherman, S S

    1. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
      E H Ohlstein, L I Kruse, M Ezekiel, S S Sherman, R Erickson, W E DeWolf and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 554-559;

  14. Spearman, M E

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
      M E Spearman, R M Goodwin, L D Apelgren and T F Bumol
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 695-703;

  15. Stewart, J

    1. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: evidence for different structural prerequisites.
      I Llona, R Vavrek, J Stewart and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 608-614;

  16. Stone, G A

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  17. Strandhoy, J W

    1. In vivo assessment of rat renal alpha adrenoceptors.
      D W Wolff, F A Gesek and J W Strandhoy
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 472-476;

  18. Stull, R W

    1. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
      G Eisenhofer, T G Ropchak, R W Stull, D S Goldstein, H R Keiser and I J Kopin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 547-553;

  19. Szabó, G

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

T

  1. Talbot, P A

    1. Potentiation of aminoglycoside-induced neuromuscular blockade by protons in vitro and in vivo.
      P A Talbot
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 686-694;

  2. Tamai, I

    1. H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine.
      A Tsuji, T Terasaki, I Tamai and H Hirooka
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 594-601;

  3. Tariq, M

    1. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
      M Tariq, N S Parmar and A M Ageel
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 602-607;

  4. Taylor, D A

    1. Characteristics of adaptive supersensitivity in the left atrium of the guinea pig.
      M H Hawthorn, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 453-457;

  5. Telegdy, G

    1. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
      G L Kovács, Z Sarnyai, F Izbéki, G Szabó, G Telegdy, T Barth, K Jost and F Brtnik
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 569-574;

  6. Terasaki, T

    1. H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine.
      A Tsuji, T Terasaki, I Tamai and H Hirooka
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 594-601;

  7. Tsubomura, T

    1. Gastric excitation by stimulation of the vagal trunk after chronic supranodose vagotomy in cats.
      T Tsubomura, T Okamoto, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 650-654;

  8. Tsuji, A

    1. H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine.
      A Tsuji, T Terasaki, I Tamai and H Hirooka
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 594-601;

U

  1. Udelsman, R

    1. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.
      S Kawai, L K Nieman, D D Brandon, R Udelsman, D L Loriaux and G P Chrousos
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 401-406;

V

  1. Vanhoutte, P M

    1. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs.
      N A Flavahan, J P Cooke, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 361-365;
    2. Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels.
      D A Houston, G Burnstock and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 501-506;

  2. Vargaftig, B B

    1. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
      M Hatmi, A del Maschio, J Lefort, G de gaetano, B B Vargaftig and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 623-627;

  3. Vaught, J L

    1. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
      F Porreca, J S Heyman, H I Mosberg, J R Omnaas and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 393-400;

  4. Vavrek, R

    1. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: evidence for different structural prerequisites.
      I Llona, R Vavrek, J Stewart and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 608-614;

  5. Vaysse, P J

    1. Modulation of rat brain opioid receptors by cannabinoids.
      P J Vaysse, E L Gardner and R S Zukin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 534-539;

  6. Vesell, E S

    1. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. I. Analysis, characterization and regulation of specific beta adrenergic receptors.
      J P Fabisiak, E S Vesell and D E Rannels
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 722-727;
    2. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. II. Receptor-independent accumulation of beta adrenergic antagonists and other cationic amphiphilic drugs in lamellar bodies.
      J P Fabisiak, E S Vesell and D E Rannels
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 728-735;

  7. Vestal, R E

    1. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men.
      R E Vestal, B J Cusack, G D Mercer, G W Dawson and B K Park
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 488-500;

W

  1. Wick, P F

    1. Alpha-1 adrenergic coupling events induced by full and partial agonists in rabbit aorta.
      P F Wick, A C Keung, J J Bowler and R C Deth
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 458-464;

  2. Williams, J S

    1. A possible role for the endothelium in porcine coronary smooth muscle responses to dihydropyridine calcium channel modulators.
      J S Williams, Y H Baik, W J Koch and A Schwartz
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 379-386;

  3. Williams, M

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  4. Wills, R J

    1. Pharmacokinetics and antisecretory activity of trimoprostil in Heidenhain-pouch dogs.
      R J Wills, H E Gallo-Torres, R Bertko and B H Min
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 433-437;

  5. Wolff, D W

    1. In vivo assessment of rat renal alpha adrenoceptors.
      D W Wolff, F A Gesek and J W Strandhoy
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 472-476;

  6. Wooten, G F

    1. In vitro and in vivo distribution and binding of phenytoin to rat brain.
      W A Geary, G F Wooten, J B Perlin and E W Lothman
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 704-713;

Y

  1. Yang, J S

    1. gamma-Aminobutyric acid receptor-regulated 36Cl- flux in mouse cortical slices.
      J S Yang and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 677-685;

  2. Yang, W C

    1. Effect of parathyroid hormone fragments on calcium transport in toad bladder.
      S Sabatini, W C Yang and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 448-452;

Z

  1. Zimmerman, D M

    1. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
      D M Zimmerman, J D Leander, J K Reel and M D Hynes
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 374-378;

  2. Zukin, R S

    1. Modulation of rat brain opioid receptors by cannabinoids.
      P J Vaysse, E L Gardner and R S Zukin
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 534-539;
Back to top

In this issue

Advertisement